Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
ACRV
#3450
Acrivon Therapeutics, Inc. Common Stock
1.5
1
-17.03%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-17.03%
Monatliche Änderung
-23.74%
6 month change
+11.03%
Jahresänderung
-71.51%
Vorheriger Schlusskurs
1.8
2
Open
1.5
1
Bid
Ask
Low
1.5
1
High
1.5
1
Volumen
10
Märkte
Aktien
Gesundheitswesen
ACRV
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
Nachrichten
아크리본 테라퓨틱스, ESGO 학회서 ACR-368 임상시험 웹캐스트 개최
아크리본, ESGO 학회에서 ACR-368 자궁내막암 데이터 발표
Acrivon to present ACR-368 endometrial cancer data at ESGO congress
Sunday’s Insider Activity: Top Executives Make Strategic Moves
Acrivon Therapeutics CEO, 8.2만 달러 자사주 매입
Acrivon Therapeutics CEO Blume-Jensen buys $82k in shares
애크리본 테라퓨틱스 COO 데브로, 1.7만 달러 자사주 매입
Acrivon Therapeutics COO Devroe buys $17k in shares
파이퍼 샌들러, Acrivon Therapeutics 목표 주가 8달러로 상향 조정
Piper Sandler raises Acrivon Therapeutics stock price target to $8 on positive cancer data
애크리본 테라퓨틱스, 암 임상 결과 발표 후 주가 급락
Acrivon Therapeutics stock plunges after mixed cancer trial results